Rat induced pluripotent stem cells protect H9C2 cells from cellular senescence via a paracrine mechanism

Cardiology (Switzerland)

Volumn 128, Issue 1, 2014, Pages 43-50

  Zhang, Yuzhen ^a   Wang, Dan ^b   Cao, Kejiang ^c   Chen, Minglong ^c   Yang, Xiangjun ^a   Tao, Yanyun ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Unit 95935 China People's Liberation Army   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cardiomyocytes; Cell therapy; Cellular senescence; Hypoxia reoxygenation; Paracrine mechanism

Indexed keywords

BETA GALACTOSIDASE; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 2A; MESSENGER RNA; PROTEIN P21; PROTEIN P53; RETINOBLASTOMA PROTEIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULOTROPIN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; SIGNAL PEPTIDE;

ANIMAL CELL; ARTICLE; CELL AGING; CELL HYPOXIA; CELL LINE; CELL PROTECTION; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; G1 PHASE CELL CYCLE CHECKPOINT; HEART MUSCLE CELL; NONHUMAN; OXIDATIVE STRESS; PARACRINE SIGNALING; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REOXYGENATION; SIGNAL TRANSDUCTION; STEM CELL CULTURE; SUPERNATANT; ADULT; ANIMAL; GENE EXPRESSION; METABOLISM; PHYSIOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; BETA-GALACTOSIDASE; CELL AGING; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION; GENES, P16; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MYOCYTES, CARDIAC; PARACRINE COMMUNICATION; PLURIPOTENT STEM CELLS; RATS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84897967228     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000357423     Document Type: Article

References (32)

1. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
2. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P: Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 1998; 95: 8801-8805.
3. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B, Anversa P: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003; 114: 763-776.
4. Kajstura J, Gurusamy N, Ogorek B, Goichberg P, Clavo-Rondon C, Hosoda T, D'Amario D, Bardelli S, Beltrami AP, Cesselli D, Bussani R, del Monte F, Quaini F, Rota M, Beltrami CA, Buchholz BA, Leri A, Anversa P: Myocyte turnover in the aging human heart. Circ Res 2010; 107: 1374-1386.
5. Singla DK, Lyons GE, Kamp TJ: Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling. Am J Physiol Heart Circ Physiol 2007; 293:H1308-H1314.
6. Singla DK, McDonald DE: Factors released from embryonic stem cells inhibit apoptosis of H9c2 cells. Am J Physiol Heart Circ Physiol 2007; 293:H1590-H1595.
7. Singla DK, Singla RD, McDonald DE: Factors released from embryonic stem cells inhibit apoptosis in H9c2 cells through PI3K/Akt but not ERK pathway. Am J Physiol Heart Circ Physiol 2008; 295:H907-H913.
8. Crisostomo PR, Abarbanell AM, Wang M, Lahm T, Wang Y, Meldrum DR: Embryonic stem cells attenuate myocardial dysfunction and inflammation after surgical global ischemia via paracrine actions. Am J Physiol Heart Circ Physiol 2008; 295:H1726-H1735.
9. LaFramboise WA, Petrosko P, Krill-Burger JM, Morris DR, McCoy AR, Scalise D, Malehorn DE, Guthrie RD, Becich MJ, Dhir R: Proteins secreted by embryonic stem cells activate cardiomyocytes through ligand binding pathways. J Proteomics 2010; 73: 992-1003.
10. Takahashi K, Yamanaka S: Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-676.
11. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U: Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008; 118: 507-517.
12. Narazaki G, Uosaki H, Teranishi M, Okita K, Kim B, Matsuoka S, Yamanaka S, Yamashita JK: Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008; 118: 498-506.
13. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A: Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells. Circulation 2009; 120: 408-416.
14. Zhang Y, Wang D, Chen M, Yang B, Zhang F, Cao K: Intramyocardial transplantation of undifferentiated rat induced pluripotent stem cells causes tumorigenesis in the heart. PLoS One 2011; 6:e19012.
15. Ahmed RP, Ashraf M, Buccini S, Shujia J, Haider H: Cardiac tumorigenic potential of induced pluripotent stem cells in an immunocompetent host with myocardial infarction. Regen Med 2011; 6: 171-178.
16. Wang D, Zhang YZ, Yang B, Zhang FX, Cao MY, Wang C, Chen ML: p21 WAF1 and hypoxia/reoxygenation-induced premature senescence of H9c2 cardiomyocytes. Folia Histochem Cytobiol 2011; 49: 445-451.
17. Liao J, Cui C, Chen S, Ren J, Chen J, Gao Y, Li H, Jia N, Cheng L, Xiao H, Xiao L: Generation of induced pluripotent stem cell lines from adult rat cells. Cell Stem Cell 2009; 4: 11-15.
18. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92: 9363-9367.
19. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, Kleijer WJ, DiMaio D, Hwang ES: Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 2006; 5: 187-195.
20. Ben-Porath I, Weinberg RA: The signals and pathways activating cellular senescence. Int J Biochem Cell Biol 2005; 37: 961-976.
21. Urbich C, Aicher A, Heeschen C, Dernbach E, Hofmann WK, Zeiher AM, Dimmeler S: Soluble factors released by endothelial progenitor cells promote migration of endothelial cells and cardiac resident progenitor cells. J Mol Cell Cardiol 2005; 39: 733-742.
22. Korf-Klingebiel M, Kempf T, Sauer T, Brinkmann E, Fischer P, Meyer GP, Ganser A, Drexler H, Wollert KC: Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008; 29: 2851-2858.
23. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, Desnos M, Hagege AA, Aranda P, Andreu EJ, Menasche P, Prosper F: Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 2008; 10: 1065-1072.
24. Kasuda S, Tatsumi K, Sakurai Y, Kato J, Taminishi S, Takeda T, Ohashi K, Okano T, Hatake K, Shima M: Expression of coagulation factors from murine induced pluripotent stem cell-derived liver cells. Blood Coagul Fibrinolysis 2011; 22: 271-279.
25. Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Lam FF, Kang S, Xia JC, Lai WH, Au KW, Chow YY, Siu CW, Lee CN, Tse HF: Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation 2010; 121: 1113-1123.
26. Wollert KC, Drexler H: Cell therapy for the treatment of coronary heart disease: a critical appraisal. Nat Rev Cardiol 2010; 7: 204-215.
27. Baraniak PR, McDevitt TC: Stem cell paracrine actions and tissue regeneration. Regen Med 2010; 5: 121-143.
28. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992; 298: 29-32.
29. Akiyama M, Hideshima T, Hayashi T, Tai YT, Mitsiades CS, Mitsiades N, Chauhan D, Richardson P, Munshi NC, Anderson KC: Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein. Cancer Res 2003; 63: 18-21.
30. Bu DX, Johansson ME, Ren J, Xu DW, Johnson FB, Edfeldt K, Yan ZQ: Nuclear factor {kappa}B-mediated transactivation of telomerase prevents intimal smooth muscle cell from replicative senescence during vascular repair. Arterioscler Thromb Vasc Biol 2010; 30: 2604-2610.
31. Tsirpanlis G: Cellular senescence, cardiovascular risk, and CKD: a review of established and hypothetical interconnections. Am J Kidney Dis 2008; 51: 131-144.
32. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ: Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107-114.